Tirzepatide, a dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, commonly causes gastrointestinal effects including nausea, diarrhea, and constipation
10.1186/s12868-017-0358-z BMC Neurosci
"L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial." J Clin Oncol 30(31): 3864-3869
Mumtaz, H., Ghafoor, B., Saghir, H., Tariq, M., Dahar, K., Ali, S
Summary: Embracing Natural GLP1 for Better Health Natural GLP1 is a powerful hormone that significantly impacts appetite control, blood sugar management, and metabolic health
Compared to other peptide therapies, ipamorelin is notable for its selective action and reduced side effect profile